<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF BIOSHIELD TECHNOLOGIES, INC. FOR THE NINE MONTHS ENDED
MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>

                             
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               MAR-31-2000
<CASH>                                       5,015,138
<SECURITIES>                                    62,132
<RECEIVABLES>                                  364,083
<ALLOWANCES>                                   200,000
<INVENTORY>                                    230,571
<CURRENT-ASSETS>                             5,894,919
<PP&E>                                       6,333,025
<DEPRECIATION>                                 453,874
<TOTAL-ASSETS>                              12,402,719
<CURRENT-LIABILITIES>                        3,924,657
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                  4,000,000
<COMMON>                                    14,689,137
<OTHER-SE>                                 (16,402,992)
<TOTAL-LIABILITY-AND-EQUITY>                12,402,719
<SALES>                                        737,182
<TOTAL-REVENUES>                               737,182
<CGS>                                          411,657
<TOTAL-COSTS>                                  411,657
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (13,531,625)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (13,288,792)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (13,314,160)
<EPS-BASIC>                                      (1.93)
<EPS-DILUTED>                                        0<F1>
<FN>
<F1>DILUTED LOSS PER COMMON SHARE IS NOT DISCLOSED BECAUSE THE EFFECT OF THE
EXCHANGE OR EXERCISE OF COMMON STOCK EQUIVALENTS WOULD BE ANTIDILUTIVE.
</FN>